Company Filing History:
Years Active: 2001
Title: Innovations by Judith E. Caterini in Immunology
Introduction
Judith E. Caterini is an inventive force in the field of immunology, located in Ajax, CA. With a total of two patents to her name, she has made significant contributions to the development of novel techniques for antigen delivery, showcasing her expertise and innovative thinking.
Latest Patents
Judith's latest patents focus on methods for delivering antigens to selected cells of the immune system using chimeric antibodies. One of her patents describes antibody molecules that are specific to surface structures of antigen-presenting cells. These antibodies are genetically modified to include an antigen moiety at a specific site, resulting in the production of novel conjugate antibody molecules. The production process involves the genetic modification of genes encoding the light and heavy chains of the surface structure-specific antibody, followed by expression in mammalian cells to produce the functional conjugate antibody. Importantly, these conjugate antibodies retain specificity for antigen-presenting cells while effectively delivering the targeted antigen, thereby enhancing the immune response in immunized hosts. This innovation offers promising applications in both diagnostic and prophylactic contexts.
Career Highlights
Judith is currently affiliated with Aventis Pasteur Limited, a leading company in vaccine development. Her work has showcased her capacity to innovate within the biotechnology sector, driving advancements that could have far-reaching implications for immunotherapy and vaccine efficacy.
Collaborations
Throughout her career, Judith has worked alongside notable colleagues such as Naveen N. Anand and Brian H. Barber. Their collaborations may have played a significant role in the development and refinement of the innovative methods she has patented, enhancing the potential impact of their collective research efforts.
Conclusion
Judith E. Caterini's contributions to immunology through her patents reflect her dedication and ingenuity. Her work in developing chimeric antibodies for targeted antigen delivery not only underscores her role as an inventor but also highlights the potential advancements in immune response therapies, marking her as a significant figure in the field.